| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $140.2M | +0.8% | +15.7% |
| Cost of Revenue | $35.1M | -0.4% | +8.0% |
| Gross Profit | $105.1M | +1.3% | +18.5% |
| R&D Expense | $39.3M | -4.0% | +17.9% |
| SG&A Expense | $26.3M | -7.8% | +6.2% |
| Operating Income | -$7.2M | +50.3% | +29.5% |
| Pre-tax Income | -$5.3M | +60.7% | +49.3% |
| Income Tax | $672K | -29.8% | +493.0% |
| Net Income | -$5.9M | +58.7% | +41.9% |
| EPS (Basic) | -$0.07 | +61.1% | +46.2% |
| EPS (Diluted) | -$0.07 | +61.1% | +46.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $191.2M | -30.1% | -33.1% |
| Accounts Receivable | $119.3M | +95.8% | +36.2% |
| Current Assets | $359.4M | -6.5% | -13.8% |
| Total Assets | $795.2M | -3.4% | -0.7% |
| Current Liabilities | $358.7M | +15.2% | +17.2% |
| Total Liabilities | $384.9M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $36.7M | +165.9% | — |
| Capital Expenditures | $1.2M | +119.0% | — |
| Investing Cash Flow | -$8.6M | -47.5% | — |
| Financing Cash Flow | -$149.6M | -216.8% | — |
| Free Cash Flow | $35.5M | +167.8% | — |
| +15.9% |
| Stockholders' Equity | $410.2M | -15.6% | -12.4% |